1160748-08-2

Basic information

• Product Name: 2-azido-N-(4-fluorophenyl)acetamide
• Synonyms: 2-azido-N-(4-fluorophenyl)acetamide
• CAS NO: 1160748-08-2
• Molecular Weight: 194.168
• Mol File: 1160748-08-2.mol
• Article Data: 16

Chemical Properties

• CAS DataBase Reference: 2-azido-N-(4-fluorophenyl)acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: 2-azido-N-(4-fluorophenyl)acetamide(1160748-08-2)
• EPA Substance Registry System: 2-azido-N-(4-fluorophenyl)acetamide(1160748-08-2)

Safety Data

• Hazardous Substances Data: 1160748-08-2(Hazardous Substances Data)

Upstream product

• 79-04-9 chloroacetyl chloride 
• 371-40-4 4-fluoroaniline 
• 2195-44-0 2-bromo-N-(4-fluorophenyl)acetamide 

Downstream Products

• 1550168-68-7 2-(4-((3-amino-6-phenyl-4-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridin-1-yl)methyl)-1H-1,2,3-triazol-1-yl)-N-(4-fluorophenyl)acetamide 

Relevant articles and documents

Synthesis and Cytotoxic Evaluation of Some New 1,2,3-Triazole Linked 2-Imino-4-(Trifuoromethyl)-Thiazolidin-4-ol Derivatives

A new series of 1,2,3-triazole tagged 2-imino-4-(trifluoromethyl)thiazolidinol derivatives was synthesized through click chemistry under Sharpless conditions and evaluated for anticancer activity against human monocytic leukemia (U937), human breast adeno

A novel series of substituted 1,2,3-triazoles as cancer stem cell inhibitors: Synthesis and biological evaluation

An alarming increase in global death toll resulting from cancer incidents, particularly due to multidrug resistance and reduced efficacy as a consequence of target mutations, has compelled us to look for novel anticancer agents. Cancer stem cells (CSCs),

Synthesis of New Thieno[2,3-d]pyrimidines Containing a 1,2,3-Triazole Ring and Their Therapeutic Response in NCI-60 Cell Line Panel

Abstract: A series of new tetrahydro[1]benzothieno[2,3-d]pyrimidines containing a 1,2,3-triazole fragment linkedthrough an oxymethylene spacer have been synthesized by click reaction of4-(prop-2-yn-1-yloxy)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidines with various aryl and alkyl azides inthe presence of copper sulfate and sodium ascorbate as a catalyst. Thestructures of the synthesized compounds were characterized by variousspectroscopic techniques (1H and13C NMR, FT-IR, and mass spectrometry), and theirin vitro anticancer activity against NCI-60 human tumor cell lines wasevaluated. Among the compounds tested, N-(pyridine-3-yl)-acetamide derivative exhibited significantactivity against several cancer cell lines, including SF-539 (CNS cancer),HCT-116 (colon cancer), OVCAR-8 (ovarian cancer), PC-3 (prostate cancer), andCCRF-CEM (leukemia).